Type 1 autoimmune diabetes is usually defined by a near-complete deficiency in insulin secretion due to the autoimmune destruction of beta cells, which is associated with the presence of anti-beta cell autoimmunity markers, particularly the autoantibodies directed to insulin, GAD, IA-2, and ZnT8. This evidence concerns the gene PTPRN and autoimmune type 1 diabetes.